Dapagliflozin (DAPA) Effects in HFpEF

Clinical trial NCT04730947 · COMPLETED

Trial details

NCT number: NCT04730947
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Heart Failure With Preserved Ejection Fraction

Start date: 2021-02-24
Primary completion: 2022-11-17
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.